Since more than a quarter of MB patients show activation of the SHH signaling pathway shown by GLI2/1 immunopositivity,11,39 activated forms of GLI2 preserve pathway activity and support survival of the tumor cells, indicating GLI2 activity as a key driver for MB.40 The gene discussed is GLI2; the disease is neoplasm.